<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 標(biāo)準(zhǔn)品 > 歐洲藥典標(biāo)準(zhǔn)品 >
    Palbociclib Rearranged Lactose Adduct
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):P139935
    產(chǎn)品名稱:Palbociclib Rearranged Lactose Adduct
    產(chǎn)品CAS:
    規(guī)格含量:1mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): P139935
    名稱: Palbociclib Rearranged Lactose Adduct
    別名: 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(4-((3S,4R,5R)-3,5,6-trihydroxy-2-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
    分子式: C??H??N?O??
    分子量: 771.81
    類別: Standards; Molecular Biology; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: Palbociclib Lactose Adduct is a lactose adduct of Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      同性尺度做爰无遮挡露器官漫画 | 啊灬啊灬啊灬快灬高潮了电影片段 | 插插插男男网站入口 | 大香蕉黄色电影 | 被各种性器折磨哭求饶av |